Cargando…
Choroidal Melanoma: A Mini Review
Choroidal melanoma is a rare malignant tumour, yet it is the most common primary intra-ocular neoplasm and second on the list of top ten most malignant melanoma sites in the body. Clinical presentation can be non-specific and includes photopsia, floaters, progressive visual field loss, and blurry vi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863301/ https://www.ncbi.nlm.nih.gov/pubmed/36662495 http://dx.doi.org/10.3390/medicines10010011 |
_version_ | 1784875299942432768 |
---|---|
author | Soliman, Noha Mamdouh, Diaa Elkordi, Aisha |
author_facet | Soliman, Noha Mamdouh, Diaa Elkordi, Aisha |
author_sort | Soliman, Noha |
collection | PubMed |
description | Choroidal melanoma is a rare malignant tumour, yet it is the most common primary intra-ocular neoplasm and second on the list of top ten most malignant melanoma sites in the body. Clinical presentation can be non-specific and includes photopsia, floaters, progressive visual field loss, and blurry vision. The tumour is quite often diagnosed clinically during fundus examination; however, the most valued diagnostic tests are A- and B-scan ultrasonography (US). Several factors affect prognosis, including the patient’s age, tumour size, histological features, and presence of metastases. Still, with primary treatment and tight surveillance, around 50% of choroidal melanoma patients metastasise. |
format | Online Article Text |
id | pubmed-9863301 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98633012023-01-22 Choroidal Melanoma: A Mini Review Soliman, Noha Mamdouh, Diaa Elkordi, Aisha Medicines (Basel) Review Choroidal melanoma is a rare malignant tumour, yet it is the most common primary intra-ocular neoplasm and second on the list of top ten most malignant melanoma sites in the body. Clinical presentation can be non-specific and includes photopsia, floaters, progressive visual field loss, and blurry vision. The tumour is quite often diagnosed clinically during fundus examination; however, the most valued diagnostic tests are A- and B-scan ultrasonography (US). Several factors affect prognosis, including the patient’s age, tumour size, histological features, and presence of metastases. Still, with primary treatment and tight surveillance, around 50% of choroidal melanoma patients metastasise. MDPI 2023-01-05 /pmc/articles/PMC9863301/ /pubmed/36662495 http://dx.doi.org/10.3390/medicines10010011 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Soliman, Noha Mamdouh, Diaa Elkordi, Aisha Choroidal Melanoma: A Mini Review |
title | Choroidal Melanoma: A Mini Review |
title_full | Choroidal Melanoma: A Mini Review |
title_fullStr | Choroidal Melanoma: A Mini Review |
title_full_unstemmed | Choroidal Melanoma: A Mini Review |
title_short | Choroidal Melanoma: A Mini Review |
title_sort | choroidal melanoma: a mini review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863301/ https://www.ncbi.nlm.nih.gov/pubmed/36662495 http://dx.doi.org/10.3390/medicines10010011 |
work_keys_str_mv | AT solimannoha choroidalmelanomaaminireview AT mamdouhdiaa choroidalmelanomaaminireview AT elkordiaisha choroidalmelanomaaminireview |